Our mission

Less preparing. More thinking.

Pharma teams make critical decisions across fragmented clinical, regulatory, scientific, patent and market data with much of it constantly changing, inconsistently structured and difficult to verify at scale.

RxClarity exists to turn that complexity into trusted, decision-ready intelligence.

Our platform combines specialist AI agents with a governed biomedical data layer to continuously monitor change, connect evidence and surface what matters. Every insight is grounded in source data, quality-checked and traceable back to the evidence behind it.

Built for enterprise workflows, RxClarity helps teams spend less time collecting and reconciling information and more time applying judgment across R&D, portfolio strategy, competitive intelligence and business development.

RxClarity does the preparing. Your teams do the thinking.

Our team

Zaharan Sofi, co-founder and CEO of RxClarity

Zaharan Sofi

CO-FOUNDER & CEO

A decade in data analytics within top healthcare consulting, supporting strategy and growth teams. Built intelligence tools in-house for a $2bn business. Ex-IRIS software consultant.

Ben Riazy, co-founder and CTO of RxClarity

Ben Riazy

CO-FOUNDER & CTO

Two decades building and scaling software products. Founder and leader of several VC-backed startups including Infinity Health.

Our advisors

Chris Crabtree, advisor to RxClarity

Chris Crabtree

ADVISOR

15+ years across pharmaceutical and life sciences, with broad expertise in commercial, portfolio strategy, and R&D.

Mark Franklin, advisor to RxClarity

Mark Franklin

ADVISOR

Formerly at DrugBank, where he spent 7+ years working across structured drug data curation and data systems supporting AI and drug discovery.